Cargando…
Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis
Diabetes mellitus (DM) is a risk factor for pancreatic ductal adenocarcinoma (PDAC) that promotes the promoter methylation of CDH1. It is still unclear whether DM can exert other epigenetic effects, such as altering microRNA (miR) expression, in PDAC. The expression of miR‐100‐5p is known to be chan...
Autores principales: | Hara, Yutaro, Mizukami, Hiroki, Yamazaki, Keisuke, Yamada, Takahiro, Igawa, Akiko, Takeuchi, Yuki, Sasaki, Takanori, Kushibiki, Hanae, Murakami, Kotaro, Kudoh, Kazuhiro, Ishido, Keinosuke, Hakamada, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397378/ https://www.ncbi.nlm.nih.gov/pubmed/37246239 http://dx.doi.org/10.1002/cjp2.326 |
Ejemplares similares
-
Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Pan, Xuekai, et al.
Publicado: (2022) -
Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
por: Uchida, Chiaki, et al.
Publicado: (2021) -
Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation
por: Saito, Takeshi, et al.
Publicado: (2017) -
Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2020) -
Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2021)